Standardized Microbiota Transplant Therapy in Crohn's Disease | MicrobiomeTrials← Back to trialsNCT06631586
Standardized Microbiota Transplant Therapy in Crohn's Disease
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-01-15Est. Completion: 2029-06-15
Enrollment target: 120 participants Locations- University of Minnesota, Minneapolis, Minnesota, United States
- NYU Langone Health, New York, New York, United States
- UT Southwestern, Dallas, Texas, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease (IBD)
This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier…
Vancouver, CanadaEst. completion Feb 1, 2027
Phase 3
Completed
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or…
Dothan, United StatesCompleted Jun 24, 2025